Health and Food Safety of Genetically Modified Foods - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Health and Food Safety of Genetically Modified Foods

Description:

... Food and Agricultural Organization (FAO) ... Food Biotechnology Council (IFBC) ... Plant biotechnology products must meet stringent performance standards ... – PowerPoint PPT presentation

Number of Views:158
Avg rating:3.0/5.0
Slides: 28
Provided by: Phar90
Category:

less

Transcript and Presenter's Notes

Title: Health and Food Safety of Genetically Modified Foods


1
Health and Food Safety of Genetically Modified
Foods
Dr. Roy L. Fuchs Regulatory Science / Scientific
Outreach Agricultural Products
2
Biotech Regulations
3
Three Phases of Safety Assessment
Discovery
Line Selection
Product Advancement
Post Market


  • Phase II
  • Biological / agronomic equivalence
  • Stringent agronomic performance and efficacy
    criteria
  • Greater than 99 of all events are eliminated
  • Key step in product evaluation for conventional
    varieties
  • Phase III
  • Detailed product safety
  • Food
  • Feed
  • Environmental
  • Phase I
  • Safety of gene, protein, crop
  • Choice of genes / proteins
  • - mechanism of action
  • Source of genes
  • history of safe use
  • ethics
  • Environmental / ecological considerations

4
Monsanto Has Carefully Selected the
ProteinsProduced in our Plant Biotechnology
Products
Type of
Protein1 Product Bt EPSPS NPTII Roundup Ready
Soybean 4 NewLeaf Potato 4 4 Bollgard
Cotton 4 4 Roundup Ready Cotton 4
4 MaisGard Corn 4 Roundup Ready Corn
4 Roundup Ready Canola2 4 1 All have a long
history of safe consumption 2 Also contains
naturally occurring glyphosate degradation
protein (GOX)
5
Cry or Bt Proteins Have a Long Historyof Safe
Consumption
  • Derived from naturally occurring Bacillus
    thuringiensis
  • Present in commercial microbial products used
    globally for gt 35 years, organic growers
  • Microbial products contain mixtures of Bt
    proteins
  • Subjected to extensive safety testing around the
    world
  • Acute (LD50s gt3 to gt5 g/kg)
  • Subchronic (NOELs 0.5 to gt8.4 g/kg/day)
  • Chronic (NOEL 8.4 g/kg/day)
  • Humans (no effect at 1 g/day for up to 5 days)

6
Safety Assessment - Phase II
Discovery
Line Selection
Product Advancement
Post Market
  • Biological / agronomic equivalence
  • Stringent agronomic performance and efficacy
    criteria
  • Greater than 99 of all events are eliminated
  • Key step in product evaluation for conventional
    varieties

7
The Approach to Assess Food / Feed Safety of
GMPlant Products is Consistent Globally and
DevelopedOver More Than a Decade
  • International scientific organizations
  • UN Food and Agricultural Organization (FAO) -
    1991, 1996, 2000
  • UN World Health Organization (WHO) - 1991, 1993,
    1995
  • International Life Science Institute (ILSI) -
    1996, 1997
  • Organization for Economic Cooperation and
    Development (OECD) - 1993, 1996, 1997, 2000
  • International Food Biotechnology Council (IFBC) -
    1990

8
General Conclusions by National and International
Scientific Organizations (FAO / WHO / OECD / ILSI)
  • Food from GM crops are not inherently less safe
    than those developed by conventional breeding
  • Types of risks for food from GM crops are of the
    same nature as those from conventional breeding
  • Same food safety assessment principles and
    standards apply (reasonable certainty of no
    harm)
  • Extensive safety assessments conducted with plant
    biotechnology products provide equal or greater
    assurance of safety of food products

9
Assessment of Food Safety
  • Standard - Reasonable certainty that no harm
    will result from intended uses under the
    anticipated conditions of consumption
  • Food is not inherently safe
  • Considered to be safe based on experience
  • Not absolute but relative safety

Ô . . . as safe as . . .
10
Use Concept of Substantial Equivalence to
Confirm . . . as safe as . . .
  • Compare food or food components from
    genetically-modified crop to conventional
    counterpart
  • Origin of genes
  • Agronomic parameters
  • Composition (key nutrients / anti-nutrients)
  • Intended use
  • Consumption
  • Ô confirmation of substantial equivalence
    results in same treatment with respect to safety

11
Outcomes of Substantial Equivalence Assessments
  • Substantially equivalent to conventional
    counterpart
  • Ô no further testing
  • Substantially equivalent to conventional
    counterpart except for introduced trait(s)
  • Ô focus assessment on trait(s) / gene
    product(s)
  • Not substantially equivalent to accepted food or
    food component
  • Ô combined nutritional / toxicological
    assessment

12
The Safety of Biotech Products is
EstablishedThrough the Following Approach
Food / Feed / Environmental Safety
  • Gene(s)
  • Source(s)
  • Molecular characterization
  • Insert / copy number / gene integrity
  • Protein(s)
  • History of safe use and consumption
  • Function / specificity / mode-of-action
  • Levels
  • Toxicology / allergenicity testing
  • Food / Feed Composition
  • Proximate analysis
  • Key nutrients
  • Key anti-nutrients
  • Animal performance assessment
  • Environmental Studies
  • Safety to non-target organisms
  • Soil degradation
  • Outcrossing
  • Susceptibility to disease

13
Insect-Protected Corn Targets (YieldGard)
  • Field
  • European Corn Borer
  • Pink Borer
  • Asian Corn Borer
  • Fall Army Worm

Larvae
  • Stored Grain
  • Indian Mealmoth
  • Angoumois Grain Moth

Adult
  • Advantages
  • Reduction in pesticide use
  • Improved insect control
  • Increased yield
  • Reduction in mycotoxin content

14
The Food and Feed Safety Assessment of
Insect-Protected Corn
  • Molecular Characterization of MON 810
  • Compositional equivalence to the parental and
    commercial varieties
  • Safety of the CryIA(b) protein
  • Wholesomeness studies in animals

15
Detailed Molecular Analysis of Insect-Protected
Corn Line MON 810
  • One DNA insertion
  • Only the cryIAb gene
  • Completely sequenced cryIAb gene
  • The cryIAb gene encodes the nature-identical
    CryIAb protein
  • CryIAb protein has gt 40 year history of safe use
    (Dipel and other commercial microbial products)

16
The Food and Feed Safety Assessmentof
Insect-Protected Corn
  • Compositional equivalence to the parental and
    commercial varieties
  • Safety of the CryIAb protein

17
Compositional Analyses Established Substantial
Equivalence
Grain Forage - Protein - Protein -
Fat - Fat - Fiber - Fiber - Starch -
Amino acid composition - Fatty acid
composition - Ash - Sugars - Calcium -
Phosphorous
Field tests conducted in the US and Europe
over multiple years Published Sanders, et al.
1999
18
Amino Acid Analysis of Grain FromInsect-Protected
Corn Line MON 810
19
Fatty Acid Analysis of Grain FromInsect-Protected
Corn Line MON 810
20
Proximate Composition of Forage From
Insect-Protected Corn Line MON 810
21
Protein Safety Assessment Shows CryIAb
  • Rapidly digested in simulated gastric juice (lt 15
    seconds)

Allergen CryIAb Allergenic source of
gene yes no Similar sequence to allergens
yes no Stable to digestion yes no Prevalent
protein in food yes no History of safe use in
microbial products
  • No deleterious effects on mammalian species in
    acute tests at gt 20 million fold exposure from
    the expected use level
  • No significant allergenic concerns

22
Principles of Food Allergy Assessment
  • Avoid transfer of known allergens
  • Assume genes from allergenic sources encode an
    allergen until proven otherwise
  • Assess the allergenic potential of all introduced
    proteins

23
Safety Assessment Summary for Insect-Protected
Corn
Component Changed Unchanged Morphology 4 Dise
ase susceptibility 4 Non-target organism
safety 4 Environmental safety 4 Agronomics
4 Composition 4 One additional gene
/ protein 4 Control of target insects 4
24
Regulatory Clearances
25
Are Biotech Plant DNA or Proteins Detectable in
Meat, Milk or Eggs?
  • Not a safety issue
  • Bt corn products have been shown to be safe
  • DNA and proteins are present in all plant
    material and are part of the diet
  • Biotech plant DNA or proteins have not been
    detected in milk, meat and eggs
  • Animal digestive systems are a hostile
    environment which degrades DNA and proteins
  • Unless rigorous precautions are taken during
    sampling and analysis, contamination may lead to
    detection

26
Summary
  • Plant biotechnology products must meet stringent
    performance standards during development
  • All products are thoroughly assessed for food,
    feed and environmental assessment prior to
    regulatory approval
  • Food / feed safety based on substantial
    equivalence and safety of expressed traits
    (proteins)
  • Composition and wholesomeness studies show that
    Bt corn is substantially equivalent to and as
    nutritious as conventional corn

27
Summary
  • Bt proteins produced in plants have a history of
    safe use
  • Bt corn is as safe as conventional corn varieties
  • Food / feed safety based on substantial
    equivalence and safety of expressed traits
    (proteins)
  • Bt proteins in MON 810 has a history of safe use
Write a Comment
User Comments (0)
About PowerShow.com